Dengue Virus (DBCOND0039413)

Identifiers

Synonyms

Dengue virus / Dengue virus (organism)

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT00880893	Study of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Subjects in Singapore	Dengue tetravalent vaccine, live Haemagglutinin-strain A(H1N1) Haemagglutinin-strain A(H3N2) Haemagglutinin-strain B Hepatitis A Vaccine	prevention	2	completed
NCT01073306	Safety and Immune Response to an Investigational Dengue Type 2 Vaccine	Dengue tetravalent vaccine, live	prevention	1	completed
NCT01084291	Evaluation of the Safety and Immune Response to an Investigational Dengue Type 1 Vaccine	No drug interventions	prevention	1	completed
NCT02794181	Zika Virus and Related Arbovirus Infections in Deferred Blood Donors (ZVADD)	No drug interventions	Not Available	Not Available	completed
NCT03141138	Comparison of Tetravalent Dengue Virus Purified Inactivated Vaccine and Tetravalent Dengue Virus Live Attenuated Vaccine	No drug interventions	prevention	1	unknown_status
NCT00788151	Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 Years	No drug interventions	prevention	2	completed
NCT00993447	Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin America	No drug interventions	prevention	2	completed
NCT00730288	Study of ChimeriVax™ Dengue Tetravalent Vaccine in Adult Subjects	No drug interventions	prevention	2	completed
NCT02305732	A Prospective, Open Label, Treatment Use Study of Patient Safety Following Transfusion of INTERCEPT Platelet Components	No drug interventions	Not Available	Not Available	completed
NCT00875524	Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Subjects	No drug interventions	prevention	2	completed
NCT00842530	Efficacy and Safety of Dengue Vaccine in Healthy Children	No drug interventions	prevention	2	completed
NCT00617344	Immunogenicity and Safety of Three Formulations of Dengue Vaccines in Healthy Adults Aged 18 to 45 Years in the US	No drug interventions	prevention	2	completed
NCT00740155	Safety and Immunogenicity of Formulations of Dengue Vaccines in Healthy Flavivirus-Naïve Adults	No drug interventions	prevention	2	completed
NCT05507450	Safety and Immunogenicity of Three V181 Dengue Vaccine Potencies in Adults (V181-003)	No drug interventions	prevention	2	completed